TRVI 基于 2025_Q4 财报的战略发展方向分析

google:search{queries:[Trevi Therapeutics TRVI 2025 Q4 financial results clinical trials Haduvio,Trevi Therapeutics Haduvio Phase 2b/3 IPF cough timeline,Trevi Therapeutics AI clinical trials drug discovery usage,Trevi Therapeutics pipeline 2026 milestones,Trevi Therapeutics business model clinical stage biotech value drivers]} Successful clinical data as catalyst for valuation>]} Renaissance of P2X3 inhibitors vs Nalbuphine ER ]} Corporate strategy and core contradiction]}